Gastrointestinal Cancers Symposium

The latest news from ASCO GI, including researcher interviews and physician perspective.


Meeting News

Moderate exercise may prolong OS in patients with metastatic colorectal cancer

January 17, 2017
Patients with metastatic colorectal cancer who engaged in moderate exercise for at least 30 minutes a day experienced reduced risks for cancer…
Meeting News CoverageVideo

VIDEO: Novel prediction model accurately determines survival in gastric cancer

February 5, 2016
SAN FRANCISCO — Daniel V.T. Catenacci, MD, a GI medical oncologist at the University of Chicago, discusses a novel gastric cancer prognostic…
Meeting News Coverage

Guest Commentary: Update on use of irreversible electroporation for locally advanced pancreatic cancer

February 3, 2016
In this guest commentary, Marcovalerio Melis, MD, FACS, discusses irreversible electroporation for locally advanced pancreatic cancer, following a
Meeting News CoveragePerspective

PD-1 blockade promising in MMR deficient GI cancers

February 3, 2016
SAN FRANCISCO — Programmed death-1 blockade demonstrated promising activity in mismatch repair deficient gastrointestinal cancers in a phase 2…
Meeting News CoveragePerspective

Ziv-aflibercept does not improve FOLFOX efficacy in gastric, GE junction cancer

February 2, 2016
SAN FRANCISCO — Adding ziv-aflibercept to FOLFOX regimens did not significantly improve survival among patients with chemotherapy-naïve…
Meeting News CoverageVideo

VIDEO: Lutathera 'an exciting new option for therapy' in midgut neuroendocrine tumors

January 29, 2016
SAN FRANCISCO — Vincent J. Picozzi, MD, a medical oncologist from Virginia Mason Medical Center in Seattle, reacts to results from the phase 3…
Meeting News CoverageVideo

VIDEO: Negative ACCORD trial results reinforce standard of care for rectal cancer

January 27, 2016
SAN FRANCISCO — Daniel Chang, MD, associate professor of radiation oncology at Stanford University, discusses the phase 3 ACCORD randomized…
Meeting News CoveragePerspective

T-DM1 not superior to taxane in HER-2–positive gastric, GE junction cancer

January 27, 2016
SAN FRANCISCO — Among patients with previously treated HER-2–positive locally advanced or metastatic gastric or gastroesophageal junction…
Meeting News CoverageVideo

VIDEO: Expert recaps three trials in gastric, esophageal cancer

January 26, 2016
SAN FRANCISCO — Daniel V. T. Catenacci, MD, a GI medical oncologist at the University of Chicago, recaps his discussion following the…
Meeting News Coverage

Vistogard effectively treats 5-FU chemotherapy toxicity

January 25, 2016
SAN FRANCISCO — Vistogard is a safe and effective life-saving antidote for cancer patients who overdosed on 5-fluorouracil or capecitabine or…